Indegene Named Leader In ISG Provider Lens For Life Sciences

07 May 2026 CW Team

Rohan Sinha, principal analyst for healthcare and life sciences at ISG, said that Indegene showed a capability driven approach supported by platforms such as the NEXT Technology Platform and Cortex. He noted that these assets enabled structured content management, workflow automation and more targeted engagement with healthcare professionals through data driven insights. He observed that the company delivered across the commercial value chain from planning to execution with emphasis on standardised processes and measurable outcomes.

Indegene's commercial operations offerings were described as helping life sciences enterprises move beyond fragmented digital initiatives to orchestrated, intelligence led execution. The NEXT Technology Platform and Cortex were said to connect content, data, workflows and engagement across channels to support consistent execution and improved operational efficiency. The firm’s use of AI and generative AI in engagement planning, forecasting and analytics, along with a broad partner ecosystem, was highlighted as driving more integrated and data led commercial models.

Vivek Ghai, executive vice president at Indegene, said that ISG's recognition affirmed the view that future commercial operations would be intelligence led and AI native by design. He added that Indegene was enabling clients to operationalise data and analytics into real world outcomes at scale with speed, precision and consistency. ISG's recognition for the third consecutive year reinforced Indegene's position as a trusted partner for companies seeking to modernise commercial operations and improve engagement effectiveness.

Information Services Group (ISG) identified Indegene Limited (Indegene) as a leader in its Provider Lens for Life Sciences Digital Services in Commercial Operations – Digital Evolution quadrant for 2026. The assessment highlighted Indegene's domain expertise, proprietary technology platforms and increased use of artificial intelligence and generative AI to enable integrated, data driven commercial operations for life sciences organisations. ISG evaluated providers on their ability to modernise planning, content, engagement, analytics and execution through digital and AI enabled models. Rohan Sinha, principal analyst for healthcare and life sciences at ISG, said that Indegene showed a capability driven approach supported by platforms such as the NEXT Technology Platform and Cortex. He noted that these assets enabled structured content management, workflow automation and more targeted engagement with healthcare professionals through data driven insights. He observed that the company delivered across the commercial value chain from planning to execution with emphasis on standardised processes and measurable outcomes. Indegene's commercial operations offerings were described as helping life sciences enterprises move beyond fragmented digital initiatives to orchestrated, intelligence led execution. The NEXT Technology Platform and Cortex were said to connect content, data, workflows and engagement across channels to support consistent execution and improved operational efficiency. The firm’s use of AI and generative AI in engagement planning, forecasting and analytics, along with a broad partner ecosystem, was highlighted as driving more integrated and data led commercial models. Vivek Ghai, executive vice president at Indegene, said that ISG's recognition affirmed the view that future commercial operations would be intelligence led and AI native by design. He added that Indegene was enabling clients to operationalise data and analytics into real world outcomes at scale with speed, precision and consistency. ISG's recognition for the third consecutive year reinforced Indegene's position as a trusted partner for companies seeking to modernise commercial operations and improve engagement effectiveness.

Real Estate

07 Jul 2026

Pecan Realty Completes Rs 1.5 Billion Transactions

Pecan Realty has recently completed four institutional transactions worth over Rs 1.5 billion over the past two years, strengthening its position as an execution-led real estate platform. The deals include resolution-led acquisitions, structured finance transactions and capital partnerships across its development portfolio.The transactions covered acquisitions through the National Company Law Tribunal process and helped provide repayment or exits to both private and public sector lenders. The company said the deals demonstrate its ability to resolve complex project situations, work with instit..

Real Estate

07 Jul 2026

SNN Estates Expands North Bengaluru Housing Project

SNN Estates has announced an expansion of its SNN Estates Felicity residential project in North Bengaluru following strong buyer demand, with 75 per cent of the first-phase inventory sold within three days of launch.The developer will add 76 apartments in the new phase, taking the project's estimated revenue potential to around Rs 1,000 crore upon completion of Phase 2.Spread across 6.5 acres in Rachenahalli, near Manyata Tech Park, the project comprises 604 apartments in 1.5, 2, 2.5, 3 and 4 BHK configurations. The development includes a 50,000-sq-ft clubhouse with amenities such as sports co..

Infrastructure Urban

07 Jul 2026

SCG Drives ASEAN Industrial Transformation Strategy

SCG is strengthening its focus on ASEAN as a key growth region by advancing industrial transformation, enhancing competitiveness and building resilient regional value chains. Thammasak Sethaudom, President and Chief Executive Officer, SCG, highlighted the need for industries to continuously develop capabilities, strengthen resilience and deepen regional cooperation to achieve sustainable long-term growth.SCG views ASEAN as an important growth engine alongside China, supported by favourable demographics, trade connectivity and investment flows. With ASEAN’s GDP projected to grow by around 4.7..